Category
Cancer
Sub Category
Breast
Study Name
S1207/B-53: Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Postive and HER2/neu Negative Breast Cancer
Principal Investigator
Gordan Srkalovic MD, PhD
Study Information
https://www.clinicaltrials.gov/ct2/show/NCT01674140?term=S1207&rank=1
Contact for Questions
Nurse - Vicki 517-364-2811

Site view: at a glance